Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cholera Toxin | 3 | 2016 | 4 | 0.650 |
Why?
|
| rho-Associated Kinases | 2 | 2019 | 8 | 0.570 |
Why?
|
| Biophysical Phenomena | 1 | 2014 | 11 | 0.450 |
Why?
|
| Molecular Docking Simulation | 2 | 2016 | 27 | 0.440 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2014 | 32 | 0.430 |
Why?
|
| Hot Temperature | 1 | 2014 | 46 | 0.430 |
Why?
|
| Escherichia coli | 1 | 2014 | 111 | 0.390 |
Why?
|
| Amino Acid Sequence | 2 | 2013 | 49 | 0.330 |
Why?
|
| Surface Plasmon Resonance | 3 | 2021 | 13 | 0.290 |
Why?
|
| Models, Molecular | 3 | 2018 | 82 | 0.280 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 2 | 2022 | 5 | 0.270 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 2 | 2008 | 8 | 0.250 |
Why?
|
| Amino Acids | 1 | 2005 | 9 | 0.240 |
Why?
|
| Protein Binding | 5 | 2021 | 115 | 0.230 |
Why?
|
| Protein Interaction Domains and Motifs | 4 | 2021 | 14 | 0.210 |
Why?
|
| Melanoma | 1 | 2022 | 28 | 0.180 |
Why?
|
| Syk Kinase | 1 | 2021 | 1 | 0.170 |
Why?
|
| Cefsulodin | 1 | 2021 | 1 | 0.170 |
Why?
|
| Integrin beta Chains | 1 | 2021 | 1 | 0.170 |
Why?
|
| Leukocytes | 1 | 2021 | 6 | 0.170 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2021 | 9 | 0.170 |
Why?
|
| Biofouling | 1 | 2021 | 10 | 0.170 |
Why?
|
| Sulfhydryl Compounds | 1 | 2021 | 14 | 0.170 |
Why?
|
| Ceftazidime | 1 | 2021 | 9 | 0.170 |
Why?
|
| Surface Properties | 2 | 2021 | 77 | 0.150 |
Why?
|
| Peptides | 1 | 2019 | 49 | 0.150 |
Why?
|
| Structure-Activity Relationship | 2 | 2018 | 44 | 0.140 |
Why?
|
| Catalytic Domain | 2 | 2019 | 13 | 0.140 |
Why?
|
| NIMA-Interacting Peptidylprolyl Isomerase | 1 | 2018 | 2 | 0.140 |
Why?
|
| Coagulants | 1 | 2018 | 2 | 0.140 |
Why?
|
| Thromboplastin | 1 | 2018 | 2 | 0.140 |
Why?
|
| Integrin alpha4beta1 | 1 | 2018 | 2 | 0.140 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2018 | 7 | 0.140 |
Why?
|
| Gene Expression | 1 | 2018 | 49 | 0.140 |
Why?
|
| Humans | 7 | 2022 | 4936 | 0.130 |
Why?
|
| Catechin | 1 | 2016 | 2 | 0.130 |
Why?
|
| Proanthocyanidins | 1 | 2016 | 2 | 0.130 |
Why?
|
| Biflavonoids | 1 | 2016 | 2 | 0.130 |
Why?
|
| Protein Conformation | 2 | 2014 | 43 | 0.130 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2022 | 37 | 0.130 |
Why?
|
| Phenols | 1 | 2016 | 13 | 0.130 |
Why?
|
| Phosphorylation | 3 | 2021 | 48 | 0.130 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2013 | 16 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 197 | 0.120 |
Why?
|
| Hydrogen Bonding | 1 | 2014 | 19 | 0.110 |
Why?
|
| Porosity | 1 | 2014 | 20 | 0.110 |
Why?
|
| Solvents | 1 | 2014 | 23 | 0.110 |
Why?
|
| Water | 1 | 2014 | 38 | 0.110 |
Why?
|
| Conserved Sequence | 1 | 2013 | 7 | 0.100 |
Why?
|
| Protein Structure, Secondary | 1 | 2013 | 22 | 0.100 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 46 | 0.100 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2013 | 3 | 0.100 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2013 | 12 | 0.100 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2013 | 11 | 0.100 |
Why?
|
| Myocardium | 1 | 2013 | 34 | 0.100 |
Why?
|
| Animals | 5 | 2019 | 1711 | 0.100 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2010 | 4 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2010 | 13 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 1 | 2010 | 18 | 0.080 |
Why?
|
| Metals | 1 | 2010 | 17 | 0.080 |
Why?
|
| Mice | 3 | 2019 | 685 | 0.080 |
Why?
|
| Binding Sites | 3 | 2016 | 66 | 0.070 |
Why?
|
| Peptide Library | 1 | 2005 | 4 | 0.060 |
Why?
|
| Mathematics | 1 | 2005 | 27 | 0.060 |
Why?
|
| CHO Cells | 2 | 2016 | 17 | 0.060 |
Why?
|
| Endothelial Cells | 2 | 2019 | 47 | 0.060 |
Why?
|
| Cricetulus | 2 | 2016 | 18 | 0.060 |
Why?
|
| Proteins | 1 | 2005 | 46 | 0.060 |
Why?
|
| CTLA-4 Antigen | 1 | 2022 | 1 | 0.050 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2022 | 4 | 0.050 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2022 | 9 | 0.050 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 27 | 0.050 |
Why?
|
| Immunotherapy | 1 | 2022 | 20 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2022 | 46 | 0.040 |
Why?
|
| THP-1 Cells | 1 | 2021 | 3 | 0.040 |
Why?
|
| Small Molecule Libraries | 1 | 2021 | 7 | 0.040 |
Why?
|
| High-Throughput Screening Assays | 1 | 2021 | 12 | 0.040 |
Why?
|
| NIH 3T3 Cells | 1 | 2019 | 7 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2019 | 18 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2019 | 19 | 0.040 |
Why?
|
| Cell Line | 1 | 2019 | 84 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2021 | 216 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 160 | 0.040 |
Why?
|
| Transcription Factor AP-1 | 1 | 2018 | 4 | 0.040 |
Why?
|
| Multiprotein Complexes | 1 | 2018 | 6 | 0.040 |
Why?
|
| Hypertension | 1 | 2019 | 58 | 0.040 |
Why?
|
| Proteolysis | 1 | 2018 | 7 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 184 | 0.040 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2018 | 5 | 0.040 |
Why?
|
| NF-kappa B | 1 | 2018 | 9 | 0.040 |
Why?
|
| Molecular Conformation | 1 | 2018 | 27 | 0.030 |
Why?
|
| Ligands | 1 | 2018 | 55 | 0.030 |
Why?
|
| Liposomes | 1 | 2018 | 24 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2018 | 140 | 0.030 |
Why?
|
| Diphtheria Toxin | 1 | 2016 | 2 | 0.030 |
Why?
|
| Exotoxins | 1 | 2016 | 2 | 0.030 |
Why?
|
| Ricin | 1 | 2016 | 2 | 0.030 |
Why?
|
| ADP Ribose Transferases | 1 | 2016 | 2 | 0.030 |
Why?
|
| Grape Seed Extract | 1 | 2016 | 2 | 0.030 |
Why?
|
| Vero Cells | 1 | 2016 | 3 | 0.030 |
Why?
|
| Virulence Factors | 1 | 2016 | 3 | 0.030 |
Why?
|
| Fruit | 1 | 2016 | 12 | 0.030 |
Why?
|
| Bacterial Toxins | 1 | 2016 | 16 | 0.030 |
Why?
|
| Vitis | 1 | 2016 | 7 | 0.030 |
Why?
|
| Plant Extracts | 1 | 2016 | 15 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2016 | 48 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2016 | 127 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 225 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2013 | 16 | 0.030 |
Why?
|
| Cricetinae | 1 | 2013 | 21 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2013 | 30 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 36 | 0.020 |
Why?
|
| Male | 1 | 2021 | 2491 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 2010 | 1 | 0.020 |
Why?
|
| Muromonab-CD3 | 1 | 2010 | 1 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2010 | 4 | 0.020 |
Why?
|
| Cations, Divalent | 1 | 2010 | 4 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2010 | 9 | 0.020 |
Why?
|
| K562 Cells | 1 | 2010 | 10 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 2010 | 4 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2010 | 7 | 0.020 |
Why?
|
| Disulfides | 1 | 2010 | 6 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2010 | 15 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2010 | 21 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 30 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2010 | 39 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 73 | 0.020 |
Why?
|
| Anilino Naphthalenesulfonates | 1 | 2008 | 1 | 0.020 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2008 | 2 | 0.020 |
Why?
|
| NAD | 1 | 2008 | 4 | 0.020 |
Why?
|
| Guanosine Triphosphate | 1 | 2008 | 6 | 0.020 |
Why?
|
| Allosteric Regulation | 1 | 2008 | 7 | 0.020 |
Why?
|
| Protein Folding | 1 | 2008 | 14 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 23 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2008 | 32 | 0.020 |
Why?
|